Correction of the cystic fibrosis defect by gene complementation in human intrahepatic biliary epithelial cell lines
Shelley A. Grubman(Tufts University), Douglas M. Jefferson(Tufts University), Henry L. Dorkin(Boston Children's Hospital), Des W. Lee(Tufts Medical Center), Andrew E. Mulberg, Ronald D. Perrone(Tufts Medical Center), Shaona L. Fang(Boston Medical Center), Seng H. Cheng(Pfizer (United States)), Alan E. Smith, Donna Armentano(Boston Medical Center), Linda C. Rogers(Boston Medical Center), Susan Murray
Cited by 40
Related Papers
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
|Annals of Internal Medicine|2003|4.6k
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
|Kidney International|2015|602
Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease
|New England Journal of Medicine|2014|524